Designing vaccines for developing-country populations: Ideal attributes, delivery devices, and presentation formats

Procedia in Vaccinology

Volumn 2, Issue 2, 2010, Pages 119-123

  Kristensen, D ^a   Zaffran, M ^b  

^a Vaccine Technologies   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cold chain; Product profile; Vaccine Presentation and Packaging Advisory Group

Indexed keywords

VACCINE;

ARTICLE; DEVELOPING COUNTRY; DEVICE; HEALTH PRACTITIONER; HEALTH PROGRAM; IMMUNIZATION; PRIORITY JOURNAL;

EID: 77955114627     PISSN: 1877282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.provac.2010.07.001     Document Type: Article

References (16)

1. World Health Organization (WHO), The United Nations Children's Fund, World Bank. 2009. State of the World's Vaccines and Immunization. 3rd ed. Geneva: WHO.
2. Weniger, B.G., M.J. Papania. 2008. Alternative vaccine delivery methods. [Chapter 61] In: Plotkin, S.A., W.A. Orenstein, and P.A. Offit. Vaccines. 5th ed. Philadelphia, PA: Saunders (Elsevier); 1357-1392.
3. Levine M.M., Robins-Browne R. Vaccines, global health and social equity. Immunol Cell Biol. 2009, 87:274-278.
4. Chen D., Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev. Vaccines. 2009, 8:547-557.
5. WHO. 2009. Workgroup 5. Cold Chain and Logistics Systems for Preparedness for the Introduction of PCV, Rotavirus, HPV and Other New Vaccines. Geneva: WHO. [Online] http://www.who.int/nuvi/NUVI_MeetingReport.pdf [7 Jan 2009, last date accessed.].
6. PATH. 2009. Optimizing Vaccine Supply Chains. Seattle: PATH. [Online] http://www.who.int/immunization_delivery/systems_policy/Optimize_urgency_EN_2009.pdf [7 Jan 2009, last date accessed.].
7. Parmar, D., E.M. Baruwa, P. Zuber, and S. Kone. 2010. Impact of wastage on single and multi-dose vaccine vials: Implications for introducing pneumococcal vaccines in developing countries. Hum Vaccin. 6: [Epub ahead of print].
8. Wong L.P. HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine. 2009, 27:1410-1415.
9. WHO. 2000. WHO Policy Statement: The Use of Opened Multi-dose Vials of Vaccine in Subsequent Immunization Sessions. Geneva: WHO. [Online] http://www.who.int/vaccines-documents/DocsPDF99/www9924.pdf [7 Jan 2010, last date accessed.].
10. WHO. 2008. Technologies and Logistics Advisory Committee (TLAC): Meeting Report 3-4 September 2008. Geneva, Switzerland. [Online] http://www.who.int/immunization_delivery/TLAC-report_2008-09.pdf.[7 Jan 2010, last date accessed.].
11. Schöndorf I., Banzhoff A., Nicolay U., Diaz Mitoma F. Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine. Vaccine. 2007, 25:1175-1182.
12. PATH, WHO. 2009. Increasing the acceptable temperature range for certain vaccines. Optimize e-newsletter. 3. [Online] http://www.who.int/immunization_delivery/systems_policy/optimize_newsletter_nov_02nov09.pdf [7 Jan 2009, last date accessed.].
13. Simerska P., Moyle P.M., Olive C., Toth I. Oral vaccine delivery-new strategies and technologies. Curr Drug Deliv. 2009, 6:347-358.
14. Prausnitz M.R., Mikszta J.A., Cormier M., Andrianov A.K. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009, 333:369-393.
15. Vaccine Presentation and Packaging Advisory Group. 2009. Generic Preferred Product Profile for Vaccines. Version 2.1. [Online] http://sites.google.com/site/vppagp/gppp. [7 Jan 2010, last date accessed.].
16. Baker, D.J., J. Jerram, and L.A. Reid. 2002. Failure of the vaccine cold chain following modification of a domestic refrigerator. J New Zealand Medical Assoc. 115:U251. [Online] http://www.nzmj.com/journal/115-1165/251/. [7 Jan 2009, last date accessed.].